FIRST-TIME LAUNCH ALLIANCE

Insights Hub

Our Insights

From Drift to Direction: Strengthening Decision-Making and Cross-Functional Collaboration for First-Time Launches

September 2, 2026
Insight Type: Webinar
View the webinar recording and learn how first-time launchers can strengthen their decision making to launch successfully.

Supply Chain Compliance for First-Time Launches: Avoiding Costly Missteps Across DSCSA, Data, and Distribution

August 12, 2026
Insight Type: Webinar
View the webinar recording and learn how supply chain compliance is more than just a DSCSA project, but requires the coordination of compliance, data, licensing, and more well before approval. Find out what should be started early to avoid launch delays. This session was led by NNIT, McKesson 3PL, and MedPro Systems.

Making AI Work for Your First Launch: Where It Drives Commercial and Medical Impact, and Where It Doesn’t

July 15, 2026
Insight Type: Webinar
View the webinar recording and learn how emerging biopharma companies can evaluate AI investments, identify high-value use cases, avoid common implementation pitfalls, and align AI capabilities with key commercial and medical launch milestones. This session was led by Beghou.

Launch Ready: From Fragmented Launch Data to Agentic Orchestration

June 30, 2026
Insight Type: Webinar
View the webinar recording and discover how first-time launch organizations can coordinate CMOs, 3PLs, and downstream partners by transforming disconnected launch data into integrated, actionable execution. This session was led by Tracelink

Launch Ready: Hiring Your First (or Next) Critical Roles

June 16, 2026
Insight Type: Webinar
View the webinar recording and understand which roles truly matter at different stages of launch readiness, how to prioritize hiring, and how to build a team structured for long-term success. This session was led by AmpersandPeople

Launch Ready: Building Supply Chain Resilience for your First Launch

June 3, 2026
Insight Type: Webinar
View the webinar recording and learn how emerging biopharma companies can design flexible, risk-resistant supply chains that withstand uncertainty while ensuring product availability at launch and beyond. This session was hosted by McKesson 3PL

Join the FTLA

A unique, collaborative forum for leaders in emerging biotech companies—from pre-IND to first launch, partnership, or acquisition.